Dataset opportunity
Markennovy — 医学影像数据集机会
Markennovy 持有的中等规模医学影像数据集，可用于诊断人工智能和计算机视觉。
Score
65.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球眼科人工智能市场 = 2024 年为 2.0923 亿美元，复合年增长率为 36.79%（来源：Grand View Research）
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
医学影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（个人身份信息审查）
Buyer persona
医疗人工智能与诊断影像公司
Markennovy 拥有一个专门的医学影像数据集，用于眼科领域，该数据集包含丰富的 `image_collection`，并结合了 `iot_data` 和 `medical_records`。这个多模态集合包括敏感的医疗处方和生物识别眼部测量数据，为训练和验证高精度诊断人工智能算法提供了全面的基础。
全球眼科人工智能市场在 2024 年的估值为2.0923 亿美元，预计将以惊人的 36.79% 的复合年增长率扩张。[5, 8] 尽管存在数据访问复杂性，例如GDPR/HIPAA 合规性、通过 Euclid Vision Group 进行的多层治理以及来自独立 ECP 的数据来源，但该数据集的稀有性和临床深度在一个市场中提供了独特的竞争优势，该市场以爆炸式增长和对高质量训练数据的巨大需求为特征。⚠ 尽职调查（有价值的数据，可协商的访问权限）：数据包括敏感的医疗处方和生物识别眼部测量数据（GDPR/HIPAA）。；由 Euclid Vision Group（美国）拥有，需要集团层面的数据治理批准。；数据部分来源于独立的眼科专业人士 (ECPs)。 · 公司：Euclid Vision Group 的子公司。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Markennovy 拥有海量的专有医学影像参数数据集，包含超过10 亿个独特数据点，用于定制眼科镜片。这些高度结构化的数据是训练蓬勃发展的眼科市场中诊断人工智能模型的首要资产，该市场预计每年增长超过 36%。对于开发下一代诊断工具的公司来说，该数据集提供了显著且稀有的竞争优势。
See dimension details ↓- Dataset Specificity90
主导的“医疗记录”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
需求异常高，这得益于眼科人工智能市场的爆炸式增长，复合年增长率为 36.79%，因此迫切需要独特、高质量的临床影像数据。[5, 8]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，Euclid Vision Group 的子公司
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
Euclid Vision Group 的子公司
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 数据需求信号（0 类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — 该公司的核心业务是制造定制隐形眼镜，这一过程会产生大量有价值的、细分市场的个体光学参数数据集，作为休眠副产品，使其成为理想目标。问题：是大型 Euclid Vision Group 的子公司，这可能会使数据所有权和决策复杂化。[7, 18]；“医学影像数据集”的初步描述可能不准确；数据包含用于镜片制造的详细光学参数
- Deep Qualification90
✓ 通过 — 目标是一家定制隐形眼镜制造商，而不是数据销售商，拥有患者特定生物识别测量数据的丰富副产品数据集；但是，由于严格执行 GDPR、Euclid Vision Group 的所有权以及数据源自独立验光师，因此访问权限很复杂。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
证据表明存在大量的制造记录，每条记录都与一只眼睛相关，并包含超过10 亿个独特参数，这对于训练人工智能识别细微的眼部状况非常有价值。
IoT / sensor data
证据表明该数据集包含与特定眼科疾病相关的制造过程数据，为旨在诊断或管理散光、老花眼和近视的人工智能模型提供了关键层。
Image collection
该数据集由验光师领导的团队捕获的精确眼部测量数据构成，确保了高质量和临床相关性，可用于开发和验证诊断人工智能算法。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time
Update frequency
Real-time
Delivery
API
Formats
Image, JSON, CSV
License
One-time license for training and validation of Diagnostic AI algorithms in ophthalmology. Usage subject to GDPR/HIPAA compliance and multi-level governance.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This dataset's value is driven by its high rarity, proprietary nature, and multimodal richness, directly supporting AI diagnostic models in the rapidly growing ophthalmology sector. The strong market demand, indicated by a 36.79% CAGR, justifies a premium valuation.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Markennovy Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in ophthalmology market = $209.23 million in 2024, CAGR 36.79% (source: Grand View Research). [1]. Investment score 62.6/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Flo — 知识库数据集机会
View opportunity →工业Jbs Tech — 维护日志数据集机会
View opportunity →工业Airborne — Industrial Operations Dataset Opportunity
View opportunity →